<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01924234</url>
  </required_header>
  <id_info>
    <org_study_id>JS004</org_study_id>
    <nct_id>NCT01924234</nct_id>
  </id_info>
  <brief_title>Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers</brief_title>
  <official_title>Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Örebro County</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether remifentanil influence the pharyngeal phase&#xD;
      of swallowing using using pressure and impedance recordings. The purpose is also to compare&#xD;
      remifentanil to morphine and younger to elderly volunteers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Remifentanil and other opioids are widely used as anesthetic sedation during minor surgical&#xD;
      procedures and as pain relief in postoperative patients when the patient is spontaneously&#xD;
      breathing and the airway is not secured by endotracheal intubation. In a previous study (not&#xD;
      yet published) we showed that remifentanil induce pulmonary aspiration in healthy volunteers&#xD;
      and the aim of this study is to objectively determine weather remifentanil infusion in&#xD;
      healthy volunteers influence the pharyngeal phase of swallowing. The purpose is also compare&#xD;
      the effect of remifentanil to morphine and younger volunteers to elderly volunteers. To&#xD;
      assess this question we are going to study 24 volunteers, 12 younger and 12 elderly, who are&#xD;
      randomised to receive remifentanil infusion with target concentration 3 ng/ml during 30&#xD;
      minutes at one occasion and an injection of morphine (younger: 0.1 mg/kg, elderly 0.07 mg/kg)&#xD;
      at the other. The volunteers are asked to swallow 10 ml normal saline several times both&#xD;
      before and after opioid administration and pharyngeal motility is parallelly recorded using&#xD;
      combined manometry and impedance catheter placed transnasally into to the pharyngo-esophageal&#xD;
      segment. Any subjective swallowing difficulties are also recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure-Flow Variables measured by combined manometry and impedance system ( ManoScan 360) during pharyngeal swallowing</measure>
    <time_frame>up to 30 minutes after opioidadministration (after start of remifentanil infusion or morphine injection)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective swallowing difficulties measured by 4-point scale</measure>
    <time_frame>Variables are measured before (baseline) and 15 min and 30 minutes after opioidadministration (after start of remifentanil infusion or morphine injection)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Pharyngeal Dysfunction</condition>
  <condition>Pharyngeal Swallowing</condition>
  <arm_group>
    <arm_group_label>morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volunteers are given morphine injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volunteers are given remifentanil infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>morphine</arm_group_label>
    <other_name>ACT-code: N02AA01</other_name>
    <other_name>Younger volunteers: injection 0.1 mg/kg</other_name>
    <other_name>Elderly volunteers: injections 0.07 mg/kg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <arm_group_label>remifentanil</arm_group_label>
    <other_name>Ultiva</other_name>
    <other_name>ATC-code: N01AH06</other_name>
    <other_name>Powder for injection/ infusion fluid solution, 1 mg Infusion TCI 3 ng/ml 30 min ( 0,15 ug/kg/min)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-30 or 65 &lt; year old healthy volunteers from both sexes.&#xD;
&#xD;
          -  Have signed and dated Informed Consent.&#xD;
&#xD;
          -  Willing and able to comply with the protocol for the duration of the trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pharyngoesophageal dysfunction&#xD;
&#xD;
          -  Known history of cardiac, pulmonary or neurological disease&#xD;
&#xD;
          -  Ongoing medication&#xD;
&#xD;
          -  Allergies to or history of reaction to remifentanil, fentanyl analogues or other&#xD;
             ingredients&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  BMI &gt; 30&#xD;
&#xD;
          -  Previous participation in a medical clinical trial where opioid has been used or have&#xD;
             during last 30 days participated in any other medicinal clinical trial or in a trial&#xD;
             where follow-up in not complete.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johanna Savilampi, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive Care, Örebro University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <study_first_submitted>August 12, 2013</study_first_submitted>
  <study_first_submitted_qc>August 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2013</study_first_posted>
  <last_update_submitted>December 2, 2014</last_update_submitted>
  <last_update_submitted_qc>December 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Örebro County</investigator_affiliation>
    <investigator_full_name>Johanna Savilampi</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Remifentanil</keyword>
  <keyword>Pharyngeal dysfunction</keyword>
  <keyword>Subjective swallowing difficulties</keyword>
  <keyword>Pulmonary aspiration</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

